8 biosimilars across immunology, oncology and endocrinology are already on the market, Sandoz Biopharmaceuticals has a leading biosimilars pipeline with more than 8 molecules in development in order to maintain its position.
Sandoz develops, manufactures and markets patent-free medicines and complex, innovative pharmaceuticals. In Germany, Sandoz is the leading provider of patent-free medicines with its product brand Hexal. Hexal products offer doctors, pharmacists and patients a broad range of treatment options. They stand for competence in research and development, for good service and economic supply. Sandoz produces Hexal drugs at several locations in Germany.
To create an IP strategy that ensures the earliest possible launch for the BU programs, taking into account the relevant development and commercial factors, and ensure alignment of such strategy with relevant stakeholders within the Novartis group.
Mindestanforderungen
Job description
Sandoz develops, manufactures and markets patent-free medicines and complex, innovative pharmaceuticals. In Germany, Sandoz is the leading provider of patent-free medicines with its product brand Hexal. Hexal products offer doctors, pharmacists and patients a broad range of treatment options. They stand for competence in research and development, for good service and economic supply. Sandoz produces Hexal drugs at several locations in Germany.
To create an IP strategy that ensures the earliest possible launch for the BU programs, taking into account the relevant development and commercial factors, and ensure alignment of such strategy with relevant stakeholders within the Novartis group.
Mindestanforderungen
Job description